ARKGvsBBCETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Clinical Trials ETF (BBC) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.65% for BBC. ARKG is up 29.47% year-to-date (YTD) with +$39M in YTD flows. BBC performs worse with 28.33% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of ARKG and BBC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs BBC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG BBC | -1.87%+1.30% | +27.92%+7.83% | +29.47%+28.33% | +45.31%+127.45% | +4.16%+114.85% | -54.66%+13.01% |
| Flows | ARKG BBC | +$81M+$83K | +$62M+$7M | +$39M+$5M | -$3M+$11M | -$550M+$15M | -$2.57B+$6M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG BBC | +44.86%+38.55% | +42.64%+35.78% | +43.40%+37.03% | +45.98%+39.66% |
| Max drawdown | ARKG BBC | -13.14%-11.64% | -27.52%-14.64% | -51.67%-54.25% | -79.29%-70.93% |
| Max drawdown duration | ARKG BBC | 18d54d | 126d60d | 1058d340d | 1814d1754d |
Trading data
ARKG | BBC | |
Last sale 7/27/2026 at 1:30 PM | $37.75 | $50.44 |
| Previous close 07/24/2026 | $37.81 | $49.67 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | BBC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
ARKG | BBC | |
|---|---|---|
| Last price | $37.75 | $50.44 |
| 1D performance | -0.16% | +1.56% |
| AuM | $1.53 B | $47.16 M |
| E/R | 0.75% | 0.65% |
Characteristics
ARKG | BBC | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Clinical Trials Index |
| N° of holdings | 31 | 125 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
86.99%
Other
13.01%
BBC
USA
85.4%
Other
14.6%
Sectors
ARKG
Healthcare
96.93%
Other
3.07%
BBC
Healthcare
95.19%
Other
4.81%
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.95%
BBC
Total weight of top 15 holdings out of 15
14.01%
Top 15 holdings
Data as of June 30, 2026
ARKG
Twist Bioscience Corp.
9.15%
Tempus AI, Inc.
7.64%
Absci Corp.
7.01%
10X Genomics, Inc.
7.00%
CRISPR Therapeutics AG
6.56%
Personalis, Inc.
6.19%
Beam Therapeutics, Inc.
4.34%
Guardant Health, Inc.
4.28%
Natera, Inc.
4.11%
Illumina, Inc.
3.98%
Veracyte, Inc.
3.24%
CareDx, Inc.
3.08%
Recursion Pharmaceuticals, Inc.
2.85%
Eli Lilly & Co.
2.81%
Compass Pathways Plc
2.70%
BBC
uniQure NV
1.18%
REGENXBIO, Inc.
1.01%
Apogee Therapeutics, Inc.
0.99%
Monopar Therapeutics, Inc.
0.97%
Jade Biosciences, Inc.
0.94%
Aktis Oncology, Inc.
0.94%
MBX Biosciences, Inc.
0.94%
Biohaven Ltd.
0.90%
Cullinan Therapeutics, Inc.
0.89%
Kymera Therapeutics, Inc.
0.89%
SELLAS Life Sciences Group, Inc.
0.89%
Generate Biomedicines, Inc.
0.88%
Intellia Therapeutics, Inc.
0.87%
Nurix Therapeutics, Inc.
0.87%
4D Molecular Therapeutics, Inc.
0.86%
Frequently asked questions about ARKG and BBC
How have the ARKG and BBC ETFs performed in 2026?
As of July 24, 2026, ARKG is up 29.47% year-to-date (YTD), while BBC has returned 28.33%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or BBC?
Year-to-date, the ARKG ETF saw +$39M in flows, compared to +$5M for BBC.
Which ETF is more volatile: ARKG or BBC?
Over the past year, ARKG had a volatility of 42.64%, while BBC experienced 35.78%.
Which ETF is bigger: ARKG or BBC?
As of July 24, 2026, ARKG holds $1.53 B in assets under management (AUM), while BBC manages $47.16 M.
What sectors do the ARKG and BBC ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, BBC focuses on Healthcare.
What are the top holdings of the ARKG ETF and BBC ETF?
ARKG top holdings include Twist Bioscience Corp., Tempus AI, Inc. and Absci Corp.. BBC holds in its top three: uniQure NV, REGENXBIO, Inc. and Apogee Therapeutics, Inc..
Which ETF is more diversified: ARKG or BBC?
ARKG holds 31 securities with 74.95% of its assets in the top 15. BBC has 125 securities and a top 15 weight of 14.01%.
Advertisement
Latest news about ARKG & BBC
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
BBC
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
